C

Compass Therapeutics
D

CMPX

2.93000
USD
-0.16
(-5.18%)
مغلق
حجم التداول
46,090
الربح لكل سهم
-0
العائد الربحي
-
P/E
-8
حجم السوق
403,136,271
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    XEMUSD
    XEMUSD
    0.000874
    (4.03%)
    0.022370 USD
    AEM
    AEM
    -1.904
    (-1.94%)
    96.120 USD
    A
    AG
    -0.20500
    (-3.56%)
    5.55500 USD
    FNV
    FNV
    -2.990
    (-2.11%)
    138.690 USD
    F
    FSM
    -0.40000
    (-8.30%)
    4.42000 USD
    GOLD
    GOLD
    -0.510
    (-2.71%)
    18.310 USD
    N
    NEM
    -2.770
    (-5.76%)
    45.340 USD
    S
    SSRM
    -0.255
    (-2.43%)
    10.240 USD
    المزيد
الأخبار
المقالات

العنوان: Compass Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.